Document Detail

Met acts through Abl to regulate p53 transcriptional outcomes and cell survival in the developing liver.
MedLine Citation:
PMID:  22889954     Owner:  NLM     Status:  MEDLINE    
BACKGROUND & AIMS: Genetic studies indicate that distinct signaling modulators are each necessary but not individually sufficient for embryonic hepatocyte survival in vivo. Nevertheless, how signaling players are interconnected into functional circuits and how they coordinate the balance of cell survival and death in developing livers are still major unresolved issues. In the present study, we examined the modulation of the p53 pathway by HGF/Met in embryonic livers.
METHODS: We combined pharmacological and genetic approaches to biochemically and functionally evaluate p53 pathway modulation in primary embryonic hepatocytes and in developing livers. RT-PCR arrays were applied to investigate the selectivity of p53 transcriptional response triggered by Met.
RESULTS: Met recruits p53 to regulate the liver developmental program, by qualitatively modulating its transcriptional properties: turning on the Mdm2 survival gene, while keeping death and cell-cycle arrest genes Pmaip1 and p21 silent. We investigated the mechanism leading to p53 regulation by Met and found that Abl and p38MAPK are required for p53 phosphorylation on S(389), Mdm2 upregulation, and hepatocyte survival. Alteration of this signaling mechanism switches p53 properties, leading to p53-dependent cell death in embryonic livers. RT-PCR array studies affirmed the ability of the Met-Abl-p53 axis to modulate the expression of distinct genes that can be regulated by p53.
CONCLUSIONS: A signaling circuit involving Abl and p38MAPK is required downstream of Met for the survival of embryonic hepatocytes, via qualitative regulation of the p53 transcriptional response, by switching its proapoptotic into survival properties.
Alessandro Furlan; Fabienne Lamballe; Venturina Stagni; Azeemudeen Hussain; Sylvie Richelme; Andrea Prodosmo; Anice Moumen; Christine Brun; Ivan Del Barco Barrantes; J Simon C Arthur; Anthony J Koleske; Angel R Nebreda; Daniela Barilà; Flavio Maina
Related Documents :
22355214 - Expression of exogenous human hepatic nuclear factor-1α by a lentiviral vector and its...
22827964 - Diurnal-and sex-related difference of metallothionein expression in mice.
2940084 - Adenovirus stimulation of transcription by rna polymerase iii: evidence for an e1a-depe...
10322454 - Histone deacetylases: transcriptional repression with siners and nurds.
11279234 - Mechanism for the reduction of telomerase expression during muscle cell differentiation.
11738794 - Intra-follicular activin availability is altered in prenatally-androgenized lambs.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't     Date:  2012-08-10
Journal Detail:
Title:  Journal of hepatology     Volume:  57     ISSN:  1600-0641     ISO Abbreviation:  J. Hepatol.     Publication Date:  2012 Dec 
Date Detail:
Created Date:  2012-11-19     Completed Date:  2013-06-21     Revised Date:  2013-12-05    
Medline Journal Info:
Nlm Unique ID:  8503886     Medline TA:  J Hepatol     Country:  Netherlands    
Other Details:
Languages:  eng     Pagination:  1292-8     Citation Subset:  IM    
Copyright Information:
Copyright © 2012 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Cell Survival
Cyclin-Dependent Kinase Inhibitor p21 / genetics
Hepatocytes / physiology*
Liver / embryology*
Proto-Oncogene Proteins c-abl / physiology*
Proto-Oncogene Proteins c-bcl-2 / genetics
Proto-Oncogene Proteins c-mdm2 / genetics
Proto-Oncogene Proteins c-met / physiology*
Transcription, Genetic*
Tumor Suppressor Protein p53 / physiology*
p38 Mitogen-Activated Protein Kinases / metabolism
Grant Support
Reg. No./Substance:
0/Cyclin-Dependent Kinase Inhibitor p21; 0/Pmaip1 protein, mouse; 0/Proto-Oncogene Proteins c-bcl-2; 0/TP53 protein, human; 0/Tumor Suppressor Protein p53; EC Proteins c-met; EC Proteins c-abl; EC Mitogen-Activated Protein Kinases; EC Proteins c-mdm2

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  CVD screening in low-risk, asymptomatic adults: clinical trials needed.
Next Document:  Raloxifene hydrochloride is an adjuvant antiviral treatment of postmenopausal women with chronic hep...